AMJ Weight Loss

AMJ Weight Loss operates as a virtual medical weight loss clinic serving patients throughout Texas, led by Dr. Mame Yacine Gueye, DNP, RN, NEA-BC. The Dallas-based practice focuses specifically on women's weight loss challenges, addressing hormonal weight gain and metabolic dysfunction through physician-supervised peptide therapy protocols. Dr. Gueye brings dual expertise as both a board-certified nurse executive and doctorate-prepared nurse practitioner, applying evidence-based approaches to complex weight management cases that have not responded to conventional diet and exercise interventions.

The clinic's treatment protocols center on two FDA-approved GLP-1 receptor agonist peptides: semaglutide and tirzepatide. Semaglutide works by mimicking the glucagon-like peptide-1 hormone to regulate appetite and slow gastric emptying, while tirzepatide activates both GLP-1 and GIP receptors for dual incretin action. AMJ Weight Loss prescribes these peptides as part of comprehensive medical weight loss programs that include metabolic assessment, dosage titration based on individual response, and ongoing monitoring of body composition changes. The clinic addresses weight gain related to perimenopause, menopause, PCOS, thyroid disorders, and insulin resistance—conditions where hormonal factors significantly impact metabolism and fat storage patterns in women.

Dr. Gueye's clinical approach integrates her nursing leadership background with advanced practice medicine, emphasizing individualized treatment plans that account for each patient's medical history, current medications, lifestyle factors, and weight loss goals. Initial consultations include comprehensive health assessments to determine peptide therapy candidacy, identify contraindications, and establish baseline metabolic markers. The practice monitors patients through regular virtual check-ins to adjust peptide dosages, manage potential side effects such as nausea or gastrointestinal changes, and provide guidance on nutrition strategies that complement GLP-1 therapy. This physician oversight distinguishes medical weight loss from commercial programs, ensuring safety and efficacy throughout treatment.

Patients access AMJ Weight Loss services entirely through telehealth platforms, eliminating travel requirements for Dallas-area residents and extending care to women across Texas cities including Houston, Austin, San Antonio, and Fort Worth. Virtual consultations allow for flexible scheduling around work and family commitments while maintaining the medical supervision necessary for prescription peptide therapy. The clinic provides detailed onboarding for patients new to injectable medications, covering proper administration techniques, storage requirements, and what to expect during the initial titration phase. Follow-up appointments track progress through weight measurements, symptom reporting, and discussion of lifestyle modifications that enhance peptide effectiveness.

AMJ Weight Loss differentiates itself through its exclusive focus on women's metabolic health and the integration of hormonal considerations into weight loss planning. The practice recognizes that female patients often experience weight loss resistance due to estrogen fluctuations, progesterone imbalances, cortisol dysregulation, and thyroid dysfunction—factors that require medical intervention beyond calorie restriction. By combining semaglutide or tirzepatide therapy with metabolism support strategies, the clinic addresses both the symptomatic weight gain and underlying hormonal contributors. The Texas-wide telehealth model provides access to specialized medical weight loss care for women in underserved areas where local providers may lack expertise in peptide therapy protocols or hormonal weight management.